2023 Q4 Form 10-K Financial Statement

#000168316824001699 Filed on March 26, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $17.21K $68.99K $36.65K
YoY Change 166.82% 88.24% -37.25%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $17.21K $68.99K $36.65K
YoY Change 166.82% 88.25% -37.26%
Operating Profit -$68.99K -$36.65K
YoY Change 88.24% -37.25%
Interest Expense $0.00 $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income -$17.21K -$68.99K -$36.65K
YoY Change 166.82% 88.24% -37.25%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$17.21K -$68.99K -$36.65K
YoY Change 166.82% 88.25% -37.26%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 $0.00
Diluted Earnings Per Share $0.00 -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 6.493M shares 6.493M shares 6.493M shares
Diluted Shares Outstanding 6.493M shares 6.493M shares

Balance Sheet

Concept 2023 Q4 2023 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00 $0.00
YoY Change
Cash & Equivalents $0.00 $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $9.110K $9.110K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $10.59K $10.59K $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $10.59K $10.59K $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $10.59K $10.59K $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $182.3K $182.3K $102.7K
YoY Change 77.47% 77.47% 64.85%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $182.3K $182.3K $102.7K
YoY Change 77.47% 77.47% 55.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $182.3K $182.3K $102.7K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $182.3K $182.3K $102.7K
YoY Change 77.47% 77.47% 55.47%
SHAREHOLDERS EQUITY
Retained Earnings -$2.495M
YoY Change 2.84%
Common Stock $6.493K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$171.7K -$171.7K -$102.7K
YoY Change
Total Liabilities & Shareholders Equity $10.59K $10.59K $0.00
YoY Change

Cashflow Statement

Concept 2023 Q4 2023 2022
OPERATING ACTIVITIES
Net Income -$17.21K -$68.99K -$36.65K
YoY Change 166.82% 88.25% -37.26%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change
Cash From Operating Activities -$9.030K -$92.24K -$25.31K
YoY Change 16.67% 264.41% -58.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.030K 92.24K $25.31K
YoY Change 16.67% 264.41% -58.0%
NET CHANGE
Cash From Operating Activities -9.030K -92.24K -$25.31K
Cash From Investing Activities $0.00 $0.00
Cash From Financing Activities 9.030K 92.24K $25.31K
Net Change In Cash 0.000 0.000 $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$9.030K -$92.24K -$25.31K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001415813
CY2023Q2 dei Entity Public Float
EntityPublicFloat
0 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
0 usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6493346 shares
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2023 dei Auditor Firm
AuditorFirmId
5041
CY2023 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2023Q4 us-gaap Cash
Cash
0 usd
CY2022Q4 us-gaap Cash
Cash
0 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
9107 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
0 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1486 usd
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
0 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
10593 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
0 usd
CY2023Q4 us-gaap Assets
Assets
10593 usd
CY2022Q4 us-gaap Assets
Assets
0 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2441 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
15101 usd
CY2023Q4 ARMC Due To Related Parties Current1
DueToRelatedPartiesCurrent1
179860 usd
CY2022Q4 ARMC Due To Related Parties Current1
DueToRelatedPartiesCurrent1
87620 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
182301 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
102721 usd
CY2023Q4 us-gaap Liabilities
Liabilities
182301 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6493346 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6493346 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6493346 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6493346 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
6493 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2317217 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2495418 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-171708 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10593 usd
CY2023 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
35543 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33444 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
68987 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-68987 usd
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-68987 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-36649 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-68987 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.011
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.006
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6493346 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6493346 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6493346 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6493346 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-66072 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-36649 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-102721 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-102721 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-68987 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-171708 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-68987 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
CY2023 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1486 usd
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-0 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-12660 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11337 usd
CY2023 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-9107 usd
CY2022 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
0 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-92240 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25312 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
92240 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
25312 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
92240 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25312 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84D_eus-gaap--UseOfEstimates_zHitdrXybefc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Use of estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s significant estimates include income taxes provision and valuation allowance of deferred tax assets; the fair value of financial instruments; the carrying value and recoverability of long-lived assets, including the values assigned to an estimated useful lives of computer equipment; and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management regularly reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_ziCucrT7FMRk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Concentration of credit risk</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments which potentially subject the Company to concentration of credit risk consist of cash deposits and customer receivables. The Company maintains cash with various major financial institutions. The Company performs periodic evaluations of the relative credit standing of these institutions. To reduce risk, the Company performs credit evaluations of its customers and maintains reserves when necessary for potential credit losses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2021Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
one-for-ten reverse stock split of its common stock. All share and earnings per share information have been retroactively adjusted to reflect the reverse stock split was recorded with the offset to additional paid-in capital.
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1276487 shares
CY2021Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1276487 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6493346 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6493346 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6493346 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6493346 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2495418 usd
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2023Q4 ARMC Due To Related Parties Current And Noncurrent1
DueToRelatedPartiesCurrentAndNoncurrent1
179860 usd
CY2022Q4 ARMC Due To Related Parties Current And Noncurrent1
DueToRelatedPartiesCurrentAndNoncurrent1
87620 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
9328 usd
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
24333 usd

Files In Submission

Name View Source Status
0001683168-24-001699-index-headers.html Edgar Link pending
0001683168-24-001699-index.html Edgar Link pending
0001683168-24-001699.txt Edgar Link pending
0001683168-24-001699-xbrl.zip Edgar Link pending
armc-20231231.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
armc-20231231_cal.xml Edgar Link unprocessable
armc-20231231_lab.xml Edgar Link unprocessable
armc-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
unmonde_ex3101.htm Edgar Link pending
unmonde_ex3102.htm Edgar Link pending
unmonde_ex3201.htm Edgar Link pending
unmonde_ex3202.htm Edgar Link pending
unmonde_i10k-123123.htm Edgar Link pending
unmonde_i10k-123123_htm.xml Edgar Link completed
armc-20231231_def.xml Edgar Link unprocessable